ORIGINAL RESEARCH article
Front. Bioeng. Biotechnol.
Sec. Industrial Biotechnology
Establishment of the first Chinese national standard for recombinant nuclease used as a process material in pharmaceutical manufacturing
Provisionally accepted- National Institutes for Food and Drug Control, Beijing, China
 
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Recombinant nuclease (RSN) is a critical raw material enzyme that is essential for removing host nucleic acids during the production of cell and gene therapy products. However, the lack of standardized quality evaluation methods and reference materials for RSN has led to the poor reliability and comparability of testing results, hindering the standardized development of related industries. To establish the first Chinese national standard for RSN activity and thereby enable the accurate and comparable quantification of enzymatic potency across laboratories and industries, high-purity candidate RSN reference materials were prepared and structurally analyzed via mass spectrometry. A robust enzymatic activity assay using herring sperm DNA as the substrate was optimized and validated in accordance with ICH Q2(R2) guidelines. The assay's specificity, accuracy, and precision were evaluated. A collaborative study involving three laboratories was then conducted to determine the potency value. The assay demonstrated excellent precision (intra-lab coefficient of variation (CV) < 5%, inter-lab CV 2.01%) and accuracy (recovery 90–110%). The candidate material showed high homogeneity and stability. Collaborative testing confirmed the study's statistical consistency (P > 0.05), and the potency was determined to be 518 U/μL. The establishment of this national standard will provide a unified reference for measuring RSN activity, enhance quality control consistency, and support the safe development and production of biopharmaceuticals, including cell and gene therapies. This standard will serve as a critical tool for regulatory evaluation and industrial applications in China.
Keywords: Recombinant nuclease, National standard, Enzymatic activity assay, herring sperm DNA substrate, methodological validation, Collaborative calibration
Received: 29 Aug 2025; Accepted: 03 Nov 2025.
Copyright: © 2025 Wang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jing  Li, li_jing@nifdc.org.cn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
